Sequani
Independent UK preclinical CRO offering GLP general, reproductive and juvenile toxicology studies for pharmaceutical and biotech sponsors.
35 contract research organizations in our directory work with Dog, across 11 countries. 34 report GLP capability and 17 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
The beagle dog is the most common non-rodent species for small-molecule toxicology and safety pharmacology, including cardiovascular telemetry. Extensive historical control data make results straightforward to interpret.
Showing 35 CROs. Order rotates daily so no lab is permanently listed first.
Independent UK preclinical CRO offering GLP general, reproductive and juvenile toxicology studies for pharmaceutical and biotech sponsors.
Preclinical in vivo pharmacology and toxicology with aerosol/inhalation expertise.
Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.
Global preclinical/clinical CRO with extensive safety assessment, pharmacology, and discovery services.
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.
CRO providing DMPK, bioanalysis, toxicology, and related preclinical services.
Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
Non-clinical CRO near Milan and part of the NMS Group, offering GLP safety assessment and toxicology, safety pharmacology and preclinical regulatory consulting to move candidates toward IND/CTA.
Government-funded Korean research institute providing GLP nonclinical safety studies, including inhalation toxicology, safety pharmacology and reproductive toxicity.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.
Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…
Preclinical GLP toxicology and safety pharmacology across small and large species.
Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.
Indian GLP-certified preclinical CRO providing toxicology and safety studies.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Preclinical CRO offering discovery, DMPK, toxicology, surgical models, and specialty pathology.
South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.
Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.
Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.
Medical device focused CRO covering biocompatibility, preclinical surgical and interventional research, histopathology and regulatory consulting. Its Minneapolis preclinical site (formerly American Preclinical Services)…
Large CRO with global preclinical safety assessment, DMPK, and bioanalytical services.
Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.
Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.
Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.
Specialty CRO focused on cardiovascular safety pharmacology and cardiovascular toxicology, including telemetry and hemodynamic studies in non-rodent species.
Integrated CRO/CDMO spanning preclinical to early clinical, including safety assessment and bioanalysis.
Translational testing and training laboratory in metro Atlanta supporting large animal preclinical device research, surgical models and procedural training.
Nonclinical CRO supporting infectious disease and other in vivo studies; bioanalysis and pathology support.
French CRO combining early clinical development with preclinical pharmacology, offering CNS and cardiovascular safety pharmacology and translational neuroscience models.